Latest Market Share News

Page 44 of 86
Perseus Mining has reported record FY25 financial results with a 16% rise in profit after tax and announced a 50% increase in dividends alongside a renewed A$100 million share buyback program.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Sprintex Limited reported a 26% revenue increase for FY25 but also a 37% rise in net loss, as it accelerates global expansion through key distribution deals and manufacturing upgrades.
Victor Sage
Victor Sage
28 Aug 2025
MotorCycle Holdings Limited delivered a robust FY2025 performance, marked by double-digit revenue growth, significant debt reduction, and expanding market share in new and used motorcycles.
Logan Eniac
Logan Eniac
28 Aug 2025
Wesfarmers Limited reported a 14.4% rise in net profit for FY2025, driven by strong retail performances and strategic portfolio moves. The company also announced a fully-franked final dividend and a significant capital management distribution, signaling confidence amid economic headwinds.
Logan Eniac
Logan Eniac
28 Aug 2025
MotorCycle Holdings Limited has delivered a standout FY2025 performance, posting record revenue and profit while slashing debt and expanding its market footprint. The company’s strategic moves into off-highway vehicles and digital channels signal a bold growth trajectory for FY2026.
Logan Eniac
Logan Eniac
27 Aug 2025
NextEd Group reported a 13.9% revenue decline in FY25, yet maintained resilient EBITDA and strengthened its cash position, signaling a strategic reset underway to capture future growth.
Victor Sage
Victor Sage
27 Aug 2025
Thorney Opportunities Ltd posted a sharp 76% decline in profit after tax for FY2025 yet declared a higher fully franked final dividend and reported growth in net tangible assets per share.
Claire Turing
Claire Turing
27 Aug 2025
Cyclopharm Limited reports a 26% revenue jump to $15.42 million in H1 2025, driven by rapid U.S. expansion and extended patent protections for its Technegas® lung imaging technology.
Ada Torres
Ada Torres
27 Aug 2025
Nova Eye Medical has reported a record A$29.3 million in FY25 revenue, driven by sustained US growth and operational improvements, setting the stage for breakeven EBITDA in the first half of FY26.
Ada Torres
Ada Torres
27 Aug 2025
Compumedics has reported record-breaking sales orders and revenues for FY25, driven by strong US market growth and SaaS adoption, setting the stage for an ambitious FY26 expansion.
Ada Torres
Ada Torres
27 Aug 2025
L1 Long Short Fund Limited reported a net profit after tax of $99.52 million for FY2025, down 42% year-on-year, yet continues its steady dividend growth with a fully franked final dividend of 6.5 cents per share.
Claire Turing
Claire Turing
27 Aug 2025
Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.
Ada Torres
Ada Torres
27 Aug 2025